- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Português (Portugal)
- Polski
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Hikma Pharmaceuticals PLC (HIK)Hikma Pharmaceuticals PLC stock price live, this page displays LON HIK stock exchange data. View the HIK premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Hikma Pharmaceuticals PLC real time stock price chart below.
What Is the Hikma Pharmaceuticals PLC Stock Price Today?
The Hikma Pharmaceuticals PLC stock price today is 1,934.00.
What Is the Stock Symbol for Hikma Pharmaceuticals PLC?
The stock symbol for Hikma Pharmaceuticals PLC is "HIK."
What Stock Exchange Does Hikma Pharmaceuticals PLC Trade On?
Hikma Pharmaceuticals PLC is listed and trades on the London stock exchange.
Is Hikma Pharmaceuticals PLC a Good Stock to Buy?
Determining whether Hikma Pharmaceuticals PLC—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the HIK quote. (ISIN: GB00B0LCW083)
What Is the Hikma Pharmaceuticals PLC Stock Price Today?
The Hikma Pharmaceuticals PLC stock price today is 1,934.00.
What Is the Stock Symbol for Hikma Pharmaceuticals PLC?
The stock symbol for Hikma Pharmaceuticals PLC is "HIK."
What Stock Exchange Does Hikma Pharmaceuticals PLC Trade On?
Hikma Pharmaceuticals PLC is listed and trades on the London stock exchange.
Is Hikma Pharmaceuticals PLC a Good Stock to Buy?
Determining whether Hikma Pharmaceuticals PLC—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the HIK quote. (ISIN: GB00B0LCW083)
1,934.00
-20.00(-1.02%)
Closed
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
1,919.00
1,957.00
52 wk Range
17.57
2,165.00
HIK Scorecard
Full Analysis
Has raised its dividend for 8 consecutive years
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
1,919.001,957.00
52 wk Range
17.572,165.00
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(3.19%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(3.19%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
HIK Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceFair Price
Upside
Technical Analysis
Neutral
Price Target
2,980.53
Upside
+54.11%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Net income is expected to grow this year
Hikma Pharmaceuticals PLC Company Profile
Hikma Pharmaceuticals PLC develops, manufactures, markets, and sells a range of generic, branded, and in-licensed pharmaceutical products. It operates through three segments: Injectables, Generics, and Branded. The Injectables segment provides generic injectable products primarily for use in hospitals. The Generics segment offers oral and other non-injectable generic products for the retail market. The Branded segment offers branded generics and in-licensed products to retail and hospital markets. The company provides its products in various therapeutic areas, including respiratory, oncology, and pain management. It also offers its products in solid, semi-solid, liquid, and injectable final dosage forms. The company operates in the United Kingdom, rest of Europe, North America, the Middle East, North Africa, and internationally. Hikma Pharmaceuticals PLC was founded in 1978 and is headquartered in London, the United Kingdom.
Compare HIK to Peers and Sector
Metrics to compare | HIK | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipHIKPeersSector | |
|---|---|---|---|---|
P/E Ratio | 19.2x | 16.0x | −0.6x | |
PEG Ratio | 0.20 | 0.03 | 0.00 | |
Price/Book | 2.4x | 2.0x | 2.6x | |
Price / LTM Sales | 1.8x | 2.1x | 3.2x | |
Upside (Analyst Target) | 22.0% | 34.3% | 45.4% | |
Fair Value Upside | Unlock | 16.1% | 7.7% | Unlock |
Analysts' Recommendations
7 Buy
3 Hold
0 Sell
Ratings:
10 analysts
Overall Consensus
Buy
Analysts 12-Month Price Target:
Average 2,354.48
(+21.74% Upside)
Dividends
Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 1.29
Dividend Yield
3.17%
Industry Median 2.52%
Annualised payout
61.8771
Paid unevenly
5-Years Growth
+14.58%
Growth Streak
People Also Watch
FAQ
What Is the Hikma Pharma (HIK) Stock Price Today?
The Hikma Pharma stock price today is 1,934.00
What Stock Exchange Does Hikma Pharma Trade On?
Hikma Pharma is listed and trades on the London stock exchange.
What Is the Stock Symbol for Hikma Pharma?
The stock symbol for Hikma Pharma is "HIK."
Does Hikma Pharma Pay Dividends? What’s The Current Dividend Yield?
The Hikma Pharma dividend yield is 3.19%.
What Is the Hikma Pharma Market Cap?
As of today, Hikma Pharma market cap is 4.27B.
What is Hikma Pharma Earnings Per Share?
The Hikma Pharma EPS is 1.29.
From a Technical Analysis Perspective, Is HIK a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Neutral.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.